This is the authors' abstract. We don't add key points for this paper.
At the end of 2019, a new coronavirus (SARS-CoV-2) was discovered in China, causing the coronavirus infection COVID-19.The ongoing COVID-19 pandemic poses a major challenge tohealth systems around the world. There is still little informationon how infection affects liver function and the significanceof pre-existing liver disease as a risk factor for infection andsevere COVID-19. In addition, some drugs used to treat thenew coronavirus infection are hepatotoxic. In this article, weanalyze data on the impact of COVID-19 on liver function, aswell as on the course and outcome of COVID-19 in patients withliver disease, including hepatocellular carcinoma, or those onimmunosuppressive therapy after liver transplantation.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Пинчук et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: